Introduction
Small-cell lung cancer (SCLC) is the most frequent neuroendocrine neoplasm in man (Parkin and Sankaranarayanan, 1994) . As a particularly fast growing cancer, it leads to early metastasis and death. Expression of various autocrine neuropeptides and their corresponding receptors as well as various other neuronal markers seems to be linked to autonomous cell growth and the neoplastic phenotype. Basic regulatory mechanisms that result in ectopic expression of neuroendocrine genes thus appear to be crucial for SCLC carcinogenesis (Heasley, 2001) . One potential modulator of neuropeptide gene expression is the neuron restrictive silencer factor (NRSF) (Quinn et al., 2002) , also known as repressor element RE1 binding transcription factor (REST) or repressor binding to the X2 box (XBR) (Chong et al., 1995; Schoenherr and Anderson, 1995; Scholl et al., 1996) . This transcription factor plays a central role in the repression of neuronal genes. The NRSF gene encodes a protein with nine zinc-finger domains that is expressed at high levels in non-neural tissues (Chong et al., 1995; Schoenherr and Anderson, 1995; Scholl et al., 1996) . It is regulated by alternative splicing generating isoforms with four, five or nine zincfinger motifs that have been extensively characterized in the rat (Palm et al., 1998 (Palm et al., , 1999 Shimojo et al., 1999 Shimojo et al., , 2001 . In humans, an isoform with four zinc-finger domains, hREST-1, has been described (Schoenherr and Anderson, 1995) . Likewise, a truncated human isoform with five zinc-finger domains referred to as sNRSF with homology to the rat neuron-specific splice variant rREST4 has recently been reported to be selectively expressed in SCLC (Coulson et al., 2000) . Although some evidence suggests that these isoforms contribute to the neuroendocrine differentiation of SCLC via dominant-negative inhibition of NRSF function (Coulson et al., 2000) , the biological role of NRSF and its specific expression in SCLC remain to be characterized.
NRSF displays its repressor effect by binding to a neuron restrictive silencer element (NRSE) located generally within the promoter regions of neuronal genes. The NRSE consensus sequence (TTC AGC ACC ACG GAC AGC GCC) has been defined experimentally comparing NRSE-like motifs within more than 20 genes (Schoenherr et al., 1996) . One gene that displays a typical NRSE binding motif (TTC AGC ACC ACG GAG AGC GTC) within the 5 0 UTR region (Schoenherr et al., 1996) is the glycine receptor a1 subunit (GLRA1). Glycine receptors are ligand-gated ion channel proteins mediating synaptic inhibition in the central nervous system (Breitinger and Becker, 2002) . The physiological expression of GLRA1 predominates in neurons, that is, postmitotic, cell cycle-arrested cells in the spinal cord, retina and brain stem (Enz and Bormann, 1995) . Various lines of evidence suggest that inactivation of the NRSF/NRSE transcriptional regulatory circuit contributes to the expression of neuronal markers in SCLC (Coulson et al., 2000) . To analyse this regulatory circuit in more detail, we characterized here the expression of GLRA1 as marker for impaired NRSE activity in SCLC biopsies and derived cell lines.
We detected GLRA1 transcripts in three out of four 'classic' SCLC cell lines (Carney et al., 1985) and in three out of five SCLC biopsy samples obtained from a cohort of 30 prospectively collected lung biopsies. Expression of GLRA1 correlated well with a reduced activity of NRSF in SCLC cells. Exogenous reconstitution of NRSF expression in SCLC cells resulted in reduced activity of NRSE-regulated reporter constructs. This inhibition was not reactivated by coexpression of the human splice variants hREST-1 (here termed NRSF-1) and sNRSF/hREST4 (here termed NRSF-4). Interestingly, expression of NRSF in NRSF-deficient SCLC cell lines effectively induced apoptosis. These results further underline the essential carcinogenic role of derepression of NRSF target genes in the pathogenesis of a specific subset of SCLC. They further suggest that modulation of the NRSF activity or its dependent target genes might be an attractive focus for novel therapeutics in the treatment of neuroendocrine neoplasms such as SCLC.
Results
Expression of GLRA1 mRNA in SCLC as an indicator for endogenous NRSF activity To monitor NRSF/NRSE activities in SCLC specimens and derived cell lines, we quantified the expression of GLRA1 by RT-PCR assays as an indirect parameter for the NRSF/NRSE activity. GLRA1 transcripts could be detected in three out of four SCLC cell lines (H69, H146 and H209). H128 SCLC cells, in contrast, did not express detectable levels of the GLRA1 transcripts. GLRA1 transcripts were moreover amplified from three out of five primary SCLC samples, but in none of 10 biopsies of patients with nonmalignant pulmonary diseases nor in 15 non-small-cell lung cancer (NSCLC) biopsies (Table 1) .
GLRA1 expression in the majority of SCLC cell lines is due to impaired NRSF-mediated silencing
The repressor activity of endogenous NRSF was further monitored by transient transfection of a reporter construct containing the NRSE from GLRA1 in H69, H128, H146 and H209 SCLC cells (S Neumann, R Seitz, A Gorzella, A Heider, M von Knebel Doeberitz, M Becker, submitted). In addition, A549 (adenocarcinoma of the lung), SW948 (colorectal cancer) and HeLa (cervical cancer) cells were included as controls for 'normal' NRSF activity. As expected, significant NRSEmediated repression of the luciferase gene was observed in A549, SW948 and HeLa cells. In agreement with the absence of GLRA1 expression, H128 SCLC cells also showed endogenous NRSF-mediated silencing of the NRSE-regulated reporter gene comparable to that of the control cell lines. In contrast, in H209 cells, the reporter activity still reached 56% of that of the control plasmid, and H69 and H146 cells displayed about 95% of the luciferase activity of the controls (Figure 1 ). 
If GLRA1 expression was directly dependent on the activity and/or expression level of NRSF, transcript levels of both genes should be inversely correlated. We therefore determined the precise expression levels of NRSF and GLRA1 transcripts by real time RT-PCR analysis in the abovementioned cell lines. Derepression of the GLRA1 gene was confirmed in H69, H146 and H209 cells, and the amount of NRSF transcripts correlated inversely with the level of the GLRA1. The highest expression levels of GLRA1 mRNA were found in H69, followed by H146 and H209 cells, whereas in the other cell lines with putative functional endogenous NRSF, no relevant levels of GLRA1 mRNA was detected (Figure 2a and b) .
Inverse correlation of GLRA1 expression and DNA binding of NRSF in SCLC cell lines
The genomic sequence of the human GLRA1 gene 5 0 UTR (Accession number U77732; Monani and Burghes, 1996) encompasses a NRSE binding motif TTC AGC ACC ACG GAG AGC GTC (Schoenherr et al., 1996) . Double-stranded 30-bp oligomer probes containing this sequence (NRSEwt) and corresponding mutant oligomers (NRSEmut) (GGA-TTC) were used to monitor NRSF binding to this NRSE in gel retardation assays. Heterologous cold competition was performed using a 21-bp oligomer (see Materials methods). To demonstrate the specificity of the band that corresponds to the NRSF/NRSE complex, we performed cold competition assays using nuclear extracts from HeLa cells that display NRSF binding activities (Chong et al., 1995) (Figure 3a) . To determine the binding activity of NRSF in low-, high-and moderate-GLRA1-expressing SCLC cells, we analysed the interaction of the endogenous NRSF with NRSE in the H128 (Figure 3b , lanes 1-4), H69 ( Figure 3b , lanes 5-8) and H146 ( Figure 3b , lanes 9-12) cells by cold competition assays as described in the previous experiment. In all band shifts generated by H128, H69 and Transcript levels of wt NRSF, NRSF-1 and NRSF-4 in SCLC are significantly lower in GLRA1-expressing SCLC than in NSCLC cell lines Specific splice variants have been proposed to exert a dominant-negative effect on wt NRSF thereby contributing to the development of the neuroendocrine phenotype of some SCLC cells (Coulson et al., 2000) . We therefore analysed the expression levels of the human NRSF splice variants; NRSF-1 and NRSF-4, using real time RT-PCR and compared it to the expression level of the wt NRSF and GLRA1 transcripts. The highest transcript levels of both of the two splice variants as well as NRSF were observed in H128 cells. Intermediate transcript levels were measured in SW948 and in HeLa cells. The three SCLC cell lines with enhanced GLRA1 expression, however, express reduced transcript levels of NRSF, NRSF-1 and NRSF-4 ( Figure  2b-d) .
In SCLC cell lines NRSF-1 and NRSF-4 have neither a significant repressor nor derepressor effect Since the endogenous GLRA1 expression is not linked to overexpression of the NRSF splice variants, we further characterized a potential interference of the NRSF splice variants and the wt NRSF using reporter gene assays. Since H146 cells showed the lowest expression levels of wt NRSF and NRSF splice variants (Figure 2b-d) , we selected this cell line for this analysis. As a control for the activity of the endogenous NRSF, we transfected the cells only with the reporter vector (Figure 4 , column pGL3-NRSE). As shown in Figure 4 , transfection of H146 cells with the vectors encoding splice variants NRSF-4 (pcNRSF-4) and NRSF-1 (pcNRSF-1) do not repress nor activate the activity of the luciferase gene controlled by an NRSE. In contrast, exogenous wt NRSF reduced the transcription of the luciferase reporter gene to 30% (Figure 4 , column pcNRSFwt). Cotransfection of H146 with a vector for the wt NRSF gene and pcNRSF-4 in a 1 : 1 ratio represses the reporter gene (Figure 4 , column pcNRSFwt : pcNRSF-4). In contrast, cotransfection with an expression vector carrying the wt NRSF gene and pcNRSF-1 in the same ratio only leads to a very discrete increase of the reporter activity (Figure 4 , column pcNRSFwt : pcNRSF-1) that is not statistically significant. These data do not support any antagonizing effect of the NRSF splice variants in the model used here.
Transient reconstitution of NRSF in H146 represses the transcription of NRSE-regulated reporter genes in a dose-dependent manner To further study the biological effect of a temporal reconstitution of NRSF expression, we transfected H146 cells with increasing amounts of an expression vector of wt NRSF (pcNRSFwt) and a constant amount of the reporter plasmid (pGL3NRSE). A ratio of 1 : 0.5 (pcNRSFwt : pGL3NRSE) was able to reduce the (Figure 5a ). This repressor effect was specific for pcNRSFwt, since transfection of an expression plasmid containing the full-length cDNA of NRSF in antisense orientation (pcNRSFwt-as) had no effect on the reporter gene activity (Figure 5b ).
Reconstitution of NRSF induces apoptosis in H146 cells
In order to determine the impact of reduced NRSF activity on the maintenance of the growth and survival of SCLC cells, we repeatedly tried to achieve stable expression of wt NRSF in H146 cells. However, transfection of pcNRSFwt and subsequent selection resulted a dramatic reduction of viable cells within 4 weeks (data not shown) and did not allow selection of surviving cell clones. We therefore assumed that continuous NRSF expression might not be compatible with survival and growth of these SCLC cells. In order to quantify a potentially toxic effect of NRSF in H146 cells, the level of apoptosis induced by transient transfection of the wt NRSF expression plasmid was determined. At 5 h post-transfection, cells were stained with propidium iodide (PI) and the fragmented DNA content was determined by flow cytometry. While transfection of the control plasmid (pcDNA3) revealed a ratio of 7% of apoptotic cells (Figure 6 , upper diagram) reconstitution of NRSF expression in H146 cells resulted in 22% of apoptotic cells (Figure 6 , lower diagram).
Discussion
NRSF is a master regulator for gene expression in neuronal precursor cells as well as in differentiated nonneuronal cells (Schoenherr and Anderson, 1995; Coulson et al., 2000) . However, dysfunctional NRSFmediated transcriptional silencing seems to be involved in the specific expression of neuropeptides that act as autocrine growth factors in SCLC cells (Coulson et al., 1999 (Coulson et al., , 2000 Quinn et al., 2002) . Thus, derepression of NRSF target genes appears to be an essential feature in SCLC carcinogenesis.
To verify this hypothesis and to study the role of NRSF-mediated transcriptional regulation for the upregulation of neuron-specific genes in SCLC and its effects on cancer cell growth, we exemplarily investigated the transcriptional regulation of the GLRA1 gene in SCLC-derived cell lines and primary SCLC biopsies, since an NRSE had been previously described in its 5 0 UTR (Schoenherr et al., 1996) . Among the cells investigated here, GLRA1 mRNA was expressed in three out of four SCLC-derived cell lines and three out of five primary SCLC biopsies, but in none of the non-SCLC-derived cell lines or pulmonary biopsies. This finding is particularly interesting in view of the fact that expression of GLRA1 has previously exclusively been observed in cell cycle-arrested postmitotic cells of the central nervous system, the retina and the adrenal planol (Betz et al., 1999; Becher et al., 1994) .
To verify that the SCLC-specific derepression of GLRA1 transcription is associated with loss of NRSFmediated transcriptional repression, we performed reporter gene assays using constructs containing the luciferase reporter gene under the control of NRSE of the 5 0 UTR of the GLRA1 gene. No significant NRSEmediated repression of the luciferase gene was observed in three out of four SCLC cell lines that express significant levels of GLRA1 transcripts. These results are in good agreement with data reported for another NRSF target genes, the arginine vasopressin (AVP), where the same correlation was found in SCLC cells (Coulson et al., 1999; Neumann et al., submitted) .
Band shift assays revealed that GLRA1 transcription in the SCLC cells analysed in this study was indeed due to reduced binding of endogenous NRSF to the GLRA1-derived NRSE. The binding activity gradually decreased from cell lines expressing low levels of GLRA1 (HeLa and H128) to GLRA1-expressing cell Recently, high expression levels of specific NRSF splice variants were observed in SCLC with reduced NRSF activity. It was therefore speculated that these splice variants might confer a dominant-negative effect on the NRSF-mediated transcriptional repression (Coulson et al., 2000) . To test this hypothesis, the transcript levels of wtNRSF, and its splice variants NRSF-1 and NRSF-4 were determined by quantitative RT-PCR. As expected, NRSF transcript levels were highest in the cell lines with significant NRSF-mediated repression (H128, Hela and SW948 cells) and were significantly lower in the SCLC cell lines without transcriptional silencing of GLRA1 (H69, H146 and H209 cells). However, similar expression levels of NRSF-1 and NRSF-4, in comparison to NRSF levels, were detected in all SCLC cell lines analysed here, independent of their NRSF activity and thus GLRA1 repression. This finding does not support a dominantnegative effect of alternatively spliced NRSF isoforms in the regulation of the GLRA1 gene. Moreover, neither significant repressor nor derepressor effects were observed for both the splice variants in transient expression assays. Comparable results have recently been described with a 'humanized' version of REST-4 in rodent neuroblastoma cells, where similarly, no evidence for the dominant-negative regulator effect of 'humanized' REST-4 (hREST4) was found (Magin et al., 2002) . Although we cannot exclude that biological effects of the two human NRSF-splice variants may depend on the cellular environment, none of the splice variants analysed here had a detectable effect on the wt NRSF-mediated transcriptional repressor function.
To further confirm that reduced or absent NRSF expression provokes enhanced expression of NRSF regulated genes as for example the GLRA1 gene in SCLC, NRSF expression was reconstituted in NRSFdeficient SCLC cells (H146) and its activity was monitored by reporter genes under control of NRSEregulated promoter constructs. These experiments revealed a dose-dependent repression of the reporter gene activity, which was not observed if an expression vector carrying the wt NRSF cDNA in antisense orientation was transfected instead of the wt NRSF expression plasmid.
Taken together, these experiments clearly demonstrate that reduced NRSF activity due to reduced NRSF expression mediates the expression of neuronal genes such as the GLRA1 in SCLC. This is particularly interesting in view of the fact that the GLRA1 gene is under physiological conditions selectively expressed in postmitotic neurons.
The consistent lack of NRSF activity in at least the majority of analysed SCLC cells further suggests that this pathway somehow might contribute to survival and or growth of these human cancer cells. To investigate a possible impact of NRSF expression on the phenotype of the NRSF-deficient SCLC cells (H146), we aimed to raise stable transfectants in that the NRSF expression had been reconstituted by exogenous expression plasmids. However, despite multiple attempts, these efforts consistently failed presumably due to severe toxic effects of the exogenous NRSF expression in these cells (data no shown). If NRSF was temporally reconstituted in H146 cells, a considerable increase of the apoptotic cells from 7% in the mock-transfected control to 22% in NRSF-transfected H146 cells was observed. A similar effect has been reported for medulloblastoma, where NRSF had been shown to be upregulated compared to neuronal progenitor cells or differentiated neurons. The effect of NRSF was antagonized by transient expression of a recombinant transcription factor, REST-VP16, constructed by replacing repressor domains of NRSF with the activation domain of a viral protein (VP16). In this experimental setting, reconstitution of a physiological NRSF-mediated transcriptional regulation was also successful, but induced the rate of apoptotic cells to 36% (Lawinger et al., 2000) . These findings further strongly support the role of deficient NRSF activity for the survival and growth of neuroendocrine cancer cells. These growth modulating properties might eventually be mediated through upregulation of ion channel receptor genes like the GLRA1. In analogy to this observation, an earlier report demonstrated an oncogenic potential of the K þ channel ether a go-go (EAG) (Pardo et al., 1999) . Thus, the detailed analysis of the regulation of neuron-specific receptor molecules and their regulatory pathways might reveal interesting new aspects to understand the biology of SCLC and might pave the road to new innovative diagnostic and therapeutic concepts.
Materials and methods

Cell lines
SCLC cell lines H69, H146, H128 and H209 as well as the NSCLC cell line A549 (bronchoalveolar cell carcinoma) and the adenocarcinoma cell lines SW 948 (colon) and HeLa (cervix uteri) were obtained from the ATCC (Manassas, VA, USA) SCLC cell lines were grown as suspension culture in RPMI 1640, and all other cell lines growing as adherent cultures were grown in Dulbecco's modified Eagle's medium (supplemented with 10% FBS and penicillin/streptomycin) at 5% CO 2 at 371C in a humidified atmosphere.
Patients and clinical samples
All biopsy samples were obtained in accordance with the ethics committee of the University of Heidelberg upon informed consent. A total of 30 patients with clinical suspect of lung cancer were included in the study: 10 patients with nonmalignant lung disease (pneumonia n ¼ 5, tuberculosis n ¼ 2, Wegener's granulomatosis n ¼ 1, sarcoidosis n ¼ 1 and cardiac pleural effusion n ¼ 1) and 20 lung cancer patients. Of each patient, one biopsy was taken during routine diagnostic bronchoscopy and was used to establish the histopathological diagnosis. A second biopsy from the same area was obtained, immediately snap-frozen in liquid nitrogen, and stored at À701C until further analysis.
RNA extraction
Cell lines RNA from cell lines was extracted using the TRIzol (Invitrogen) reagent according to the manufacturer's instructions.
Clinical samples Frozen tissue sections of the endobronchial punch biopsies were prepared in a cryostat. These tissue sections were immediately resuspended in lysis buffer and RNA was extracted using RNeasy Mini RNA-extraction kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions.
Reverse transcription
First-strand cDNA synthesis of 2 mg of total RNA was performed using MMLV-reverse transcriptase (Superscript plus, Life Technologies) and 50 ng random hexameres in a total volume of 20 ml as suggested in the manufacturers' instructions.
GLRA1-specific nested PCR
Five out of 20 ml cDNA were subjected to 40 cycles of a first GLRA1-specific PCR amplification. The following primers were designed for GLRA1 detection (sense: 5 0 -TTA ACA AAC AGC AAT ACT CTT CG-3 0 and antisense: 5 0 -ATA GTC CAT GGT TGT CTC AGC-3 0 ) at 561C. Amplification products (5 ml) of the first PCR were subjected to another 40 cycles of a nested PCR reaction with the following primers (sense: 5 0 -GAC CCC CTC GCT CCA ATT TCC-3 0 and antisense: 5 0 -TCT CCC CAT TAG CTT ATC CAG GAA ATC C-3 0 ) at the same conditions as for the first PCR, but at an annealing temperature of 641C. The integrity of the isolated RNA preparations was controlled by amplification of glyceraldehyde phosphate dehydrogenase (GAPDH) transcripts as described previously. All PCR products were electrophoresed on 2% agarose gels and visualized by ethidium bromide (0.05 mg/ml) staining.
Real-time PCR
The cDNA prepared was aliquoted into microtiter plates with each well containing cDNA produced from 100 ng total RNA. Subsequently, 6.25 ml TaqMan and antisense 5 0 -ATG CTA TCA CCT CCC CTG TGT G-3 0 ; Genbank Accession no. NM_001101) PCR amplification was performed and data were generated on an ABI Prism 7700 sequence detector and analysed using relative expression to the housekeeping gene b-actin. An amplification plot for each sample was generated showing the increase in fluorescence with each amplification cycle. From each amplification plot, a threshold cycle (Ct) value was calculated, representing the PCR cycle number at which the fluorescence was detectable above an arbitrary threshold, based on the variability of the base line data in the first 15 cycles.
Reporter constructs
The GLRA1 promoter/Luciferase reporter construct pGL3-NRSE contains two copies of the NRSE within a 132 bp fragment of the 5 0 UTR of the human GLRA1 gene (À948 to À817) cloned into the XhoI and BglII sites of the pGL3-control vector (Promega). The insert is located upstream of the luciferase gene under the control of SV40 promoter (Neumann et al., submitted) .
Expression constructs
For construction of plasmids encoding NRSF (Genbank Accession no. U22314) and NRSF-1 (Genbank Accession no. U13877), DNA fragments were generated by PCR amplification of DNA from HeLa using the primers 43. for (5 0 -TAC AGT TAT GGC CAC CCA GG-3 0 ) and 3351.rev (5 0 -AAG TTT CAT TAC TCC TGC CCT TG 3 0 ) for the amplification of NRSF and 43. for (5 0 -TAC AGT TAT GGC CAC CCA GG-3 0 ) and 1303. rev (5 0 -CCT TTT TCT CAA GCA CTA CTT AAC TAA CC-3 0 ) for the amplification of NRSF-1. Both DNA fragments were cloned into the EcoRI site of the CMV promoter-containing expression vector pcDNA3 (Invitrogen). The resulting expression vectors were designated pcNRSFwt and pcNRSF-1, respectively. To construct the expression vector pcNRSF-4, we inserted the annealed oligonucleotides 5 0 TAT GCG TAC TCA TTC AGT GGG GTA TGG ATA CCA TTT GGT AAT ATT TAC TAG AGT GTG AC-3 0 and 5 0 -TCG AGT CAC ACT CTA GTA AAT ATT ACC AAA TGG TAT CCA TAC CCC CAC TGA ATG AGT ACG CA-3 0 between the NdeI and XhoI sites of the NRSF expression vector pcNRSFwt. The insert contains the additional alternatively spliced 50 bp exon of sNRSF (Genbank Accession no. AF228045) as described previously (Coulson et al., 2000) . All constructs were confirmed by DNA sequencing.
Transfection experiments
Transient transfections of the cervical cancer cell line HeLa and the NSCLC cell line A549 were performed using effectene transfection reagent (QIAGEN). The colorectal cancer cell line SW948 was transfected using superfect transfection reagent (QIAGEN). Transfections with both the abovementioned transfection reagents were carried out according to the manufacturer's instructions. All SCLC cell lines were transfected by electroporation. Briefly, a gene pulser II System (BioRad), settings:220 V and 950 mF, was used to deliver a total DNA amount of 40 mg to a single-cell suspension of 10 7 cells prepared by manual disaggregation. The cells were then allowed to recover briefly before they were placed in normal growth medium.
Reporter gene assays
After an expression period of 44 h, cells were washed twice in PBS and either scraped off the culture dishes (adherent cells) or resuspended (cells growing in suspension culture) in 200 ml of lysis buffer (25 mm Tris-P0 4 (pH 8.0), 2 mm DTT, 2 mm trans-1,2-diaminocyclohexane N,N,N 0 ,N 0 -tetraacetic acid, 10% glycerine and 1% Triton X-100). Cell lysates underwent two cycles of freezing and thawing and nonsoluble debris was pelleted by centrifugation. Each supernatant was used to determine luciferase and b-galactosidase activity as previously described (Gossen and Bujard, 1992) .
Electrophorectic mobility shift assays
Nuclear extracts from cells were prepared as described previously (Andrews and Faller, 1991) . Oligonucleotides were designed as overhanging complementary strands. Oligonucleotides (200 ng) were annealed by denaturing at 941C and cooling slowly to room temperature, labeled with 10 mCi/ml) [g-32P]ATP (Amersham) using T4 Polynucleotide Kinase (Roche Diagnostics). Gel shift assays were performed in a 20 ml final volume of binding buffer containing 20 mmol/l HEPES, pH 7.9, 10% glycerol, 2.5 mmol/l MgCl 2 , 250 mmol/l KCl, 1 mmol/l DTT, 0.1% NP-40, and 2 mg of poly dI-dC (deoxyinosinic-deoxycytidylic acid). The nuclear extracts (5-10 mg) were incubated with 1 Â 10 4 c.p.m. labeled oligonucleotide probes for 30 min at room temperature in the presence or absence of 100-fold molar excess of unlabeled homologous or heterologous competitor NS (5 0 -CGC TTG ATG ACT CAG CCG GAA-3 0 and 5 0 -TTC CGG CTG AGT CAT CAA GCG-3 0 , TRE sequence specifically binding to the transcription factor AP-1 (Lee et al., 1987) ). The DNA-protein complexes were resolved on 5.5% nondenaturing polyacrylamide gel (29 : 1 crosslinking ratio), dried and exposed overnight to Kodak X-Omat films.
Immunoblotting
Nuclear extracts (30 mg) were separated by 6% SDS-polyacriylamide gel electrophoresis and subsequently electrophoretically transfered to a nitrocellulose membrane (Amersham Life Sciences). Equal loading of the protein was verified by Ponceau-red staining. The membrane was blocked with 5% nonfat dry milk in TBS buffer containing 0.1% Tween 20 (TBS-T) for 1 h at room temperature, and incubated with anti-NRSF MAb (12C11-1, generously provided by Dr Anderson, California Institute of Technology, Howard Hughes Medical Institute, USA) overnight at 41C. After washing three times with PBS-T, the membrane was incubated for 1 h with horseradish peroxidase-coupled anti-mouse IgG 1 : 5000 (Promega, Madison WI, USA). NRSF signal was detected using ECL Western blotting detection reagents (Amersham Pharmacia Biotech).
FACS analysis
After an expression period of 5 h, the apoptotic fraction of H146 cells (transfected either with pcDNA3 or pcNRSFwt) was determined cytometrically using FACScan equipment (Becton Dickinson) after permeabilization and PI staining of the cells (Nicoletti et al., 1991) . Briefly, 1.5 ml of hypotonic PI solution (50 mg/ml in 0.1% sodium citrate 0.1% Triton X-100) was added to 6 Â 10 6 transfected cells and were incubated overnight at 41C in the dark. The PI fluorescence of individual nuclei was analysed using the Cell Quest software (Beckton Dickinson).
Statistical analysis
The number of patients with SCLC or other disease were analysed by the exact test according to Fisher. The cell expression data (quantitative measurements) were analysed by parametric statistical methods. The means of pairs of independent samples were compared by the corresponding ttest adjusted for possible variance inhomogeneity. Three or more independent samples were investigated for a difference between at least two means by one-factorial analysis of variance. In a second step, each pair of means was compared by the Scheffe´test. Finally, the effect of different treatments of various cell lines was assessed by two-factorial analysis of variance. P-values less than 0.05 were considered to be statistically significant.
